Adaptive treatment policies must adjust to each patient's changing condition, but real-world data is rarely clean. Biomarker measurements can be noisy, and the underlying disease dynamics may shift over time or across patient groups. A new preprint on arXiv proposes a robust reinforcement learning framework designed to handle these uncertainties when learning treatment policies.
The framework is built for dynamic treatment regimes, meaning it learns sequential decisions rather than a one-time intervention. By explicitly accounting for errors in measured biomarkers and shifts in disease dynamics, the approach aims to produce policies that remain reliable even when the model does not perfectly match reality.
The significance lies in generalization: treatment policies learned from historical data often fail when applied to new patients or changed conditions. This work targets that gap, offering a path toward more trustworthy adaptive treatment recommendations in clinical settings.